Proteomics,Multiomics

Dataset Information

0

An immunoproteomic approach to characterize the CAR interactome and signalosome

ABSTRACT: Adoptive transfer of chimeric antigen receptor (CAR)-T cells is expected to become the first line of treatment for multiple malignancies, following the enormous success of anti-CD19 therapies. However, their mechanism of action is not fully understood, and clear guidelines for the design of safe and efficient receptors are missing. We hereby describe a systematic analysis of the CAR “interactome” in human primary T cells, which allowed us to identify molecular traits that influence CAR-T cell efficacy. Interactome analysis was based on immunoprecipitation of CARs followed by protein identification by mass spectrometry.

OTHER RELATED OMICS DATASETS IN: GSE102823

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): T Cell, Cell Culture, T-lymphocyte

DISEASE(S): Cancer

SUBMITTER: John Koomen  

LAB HEAD: Daniel Abate-Daga

PROVIDER: PXD007085 | Pride | 2019-11-07

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
20160531_CAR2_Fraction1-1.raw Raw
20160531_CAR2_Fraction1-1.raw (F004545).mzid_20160531_CAR2_Fraction1-1.raw_(F004545).pride.mgf.gz Mzid
20160531_CAR2_Fraction1-1.rawF004545.mzid.gz Mzid
20160531_CAR2_Fraction1-1.rawF004545.mzid_20160531_CAR2_Fraction1-1.raw_F004545.MGF Mzid
20160531_CAR2_Fraction1-1.raw_(F004545).pride.mgf.gz Mgf
Items per page:
1 - 5 of 174
altmetric image

Publications

Adoptive transfer of T cells that express a chimeric antigen receptor (CAR) is an approved immunotherapy that may be curative for some hematological cancers. To better understand the therapeutic mechanism of action, we systematically analyzed CAR signaling in human primary T cells by mass spectrometry. When we compared the interactomes and the signaling pathways activated by distinct CAR-T cells that shared the same antigen-binding domain but differed in their intracellular domains and their in  ...[more]

Similar Datasets

Transcriptomics Targeted scRNA-seq and AbSeq of human CAR-T cell infusion product from 28 cancer patients
2023-07-24 | E-MTAB-12407 | biostudies-arrayexpress
Transcriptomics Separation of mouse ES cell-derived mesodermal cells based on the expression of Flk1, PDGFRa and CAR.
2015-05-22 | E-GEOD-58170 | biostudies-arrayexpress
Proteomics CAR T cells inhibit B cell activating phosphorylation in their targets
2022-01-28 | PXD028109 | Pride
Proteomics Coxsackievirus Adenovirus Receptor co-ordinates pro-inflammatory responses in the lung epithelium
2022-09-20 | PXD029237 | Pride
Transcriptomics Generation of clinical grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of B-cell malignancies
2016-06-29 | E-GEOD-68003 | biostudies-arrayexpress
Transcriptomics Monocyte-derived IL-1 and IL-6 are differentially required for cytokine release syndrome and neurotoxicity by CAR-T cells.
2018-05-24 | E-MTAB-6505 | biostudies-arrayexpress
Proteomics Global phosphoproteomic analysis of signaling by distinct chimeric antigen receptors reveals kinetic and quantitative differences that influence cell function
2018-08-13 | PXD007921 | Pride
Proteomics,Multiomics An immunoproteomic approach to characterize the CAR interactome and signalosome
2019-11-07 | PXD007086 | Pride
Transcriptomics Bulk mRNA Seq CAR.CCR7 vs. CAR
2023-06-30 | E-MTAB-12778 | biostudies-arrayexpress
Proteomics,Multiomics Transfer of antigen target into CAR T cells via trogocytosis
2019-03-29 | PXD012833 | Pride